ID   RIOK2_HUMAN             Reviewed;         552 AA.
AC   Q9BVS4; Q9NUT0;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 2.
DT   02-NOV-2010, entry version 85.
DE   RecName: Full=Serine/threonine-protein kinase RIO2;
DE            EC=2.7.11.1;
DE   AltName: Full=RIO kinase 2;
GN   Name=RIOK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-349.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT TYR-144.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-380; SER-382; SER-385 AND SER-390, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=19007248; DOI=10.1021/ac801708p;
RA   Wang B., Malik R., Nigg E.A., Korner R.;
RT   "Evaluation of the low-specificity protease elastase for large-scale
RT   phosphoproteome analysis.";
RL   Anal. Chem. 80:9526-9533(2008).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-350; SER-380; SER-382; SER-385; SER-390; SER-417 AND SER-442, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-350; SER-380; SER-382; SER-385 AND SER-442, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332 AND SER-337, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-350; SER-362; SER-369; SER-380; SER-382; SER-385; SER-390;
RP   SER-442; TYR-445; THR-481; SER-483; SER-486; SER-487 AND SER-489, AND
RP   MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332; SER-335; SER-337;
RP   SER-380; SER-382; SER-385 AND SER-390, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-96; ARG-144; HIS-155; ILE-175;
RP   THR-216; VAL-244; ARG-349; SER-397; ASP-409 AND HIS-507.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. RIO-type
CC       Ser/Thr kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK002021; BAA92040.1; -; mRNA.
DR   EMBL; BC000953; AAH00953.1; -; mRNA.
DR   IPI; IPI00306406; -.
DR   RefSeq; NP_060813.2; -.
DR   UniGene; Hs.27021; -.
DR   ProteinModelPortal; Q9BVS4; -.
DR   SMR; Q9BVS4; 5-293.
DR   STRING; Q9BVS4; -.
DR   PhosphoSite; Q9BVS4; -.
DR   PRIDE; Q9BVS4; -.
DR   Ensembl; ENST00000283109; ENSP00000283109; ENSG00000058729.
DR   GeneID; 55781; -.
DR   NMPDR; fig|9606.3.peg.25549; -.
DR   UCSC; uc003kmz.1; human.
DR   CTD; 55781; -.
DR   GeneCards; GC05M096496; -.
DR   H-InvDB; HIX0005057; -.
DR   HGNC; HGNC:18999; RIOK2.
DR   HPA; HPA005681; -.
DR   PharmGKB; PA134885533; -.
DR   eggNOG; prNOG14914; -.
DR   HOGENOM; HBG746084; -.
DR   HOVERGEN; HBG056045; -.
DR   InParanoid; Q9BVS4; -.
DR   OMA; GGCNKIL; -.
DR   OrthoDB; EOG9JT2RG; -.
DR   PhylomeDB; Q9BVS4; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 60867; -.
DR   ArrayExpress; Q9BVS4; -.
DR   Bgee; Q9BVS4; -.
DR   CleanEx; HS_RIOK2; -.
DR   Genevestigator; Q9BVS4; -.
DR   GermOnline; ENSG00000058729; Homo sapiens.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR018934; RIO-like_kinase.
DR   InterPro; IPR015285; RIO2_kinase_winged_hlx_N.
DR   InterPro; IPR018935; RIO_kinase_CS.
DR   InterPro; IPR011991; WHTH_trsnscrt_rep_DNA-bd.
DR   Gene3D; G3DSA:1.10.10.10; Wing_hlx_DNA_bd; 1.
DR   Pfam; PF01163; RIO1; 1.
DR   Pfam; PF09202; Rio2_N; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; FALSE_NEG.
DR   PROSITE; PS01245; RIO1; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    552       Serine/threonine-protein kinase RIO2.
FT                                /FTId=PRO_0000213527.
FT   DOMAIN      271    552       Protein kinase.
FT   ACT_SITE    228    228       Proton acceptor (By similarity).
FT   BINDING     123    123       ATP (By similarity).
FT   MOD_RES     332    332       Phosphoserine.
FT   MOD_RES     335    335       Phosphoserine.
FT   MOD_RES     337    337       Phosphoserine.
FT   MOD_RES     350    350       Phosphoserine.
FT   MOD_RES     362    362       Phosphoserine.
FT   MOD_RES     369    369       Phosphoserine.
FT   MOD_RES     380    380       Phosphoserine.
FT   MOD_RES     382    382       Phosphoserine.
FT   MOD_RES     385    385       Phosphoserine.
FT   MOD_RES     390    390       Phosphoserine.
FT   MOD_RES     412    412       Phosphoserine (By similarity).
FT   MOD_RES     417    417       Phosphoserine.
FT   MOD_RES     442    442       Phosphoserine.
FT   MOD_RES     445    445       Phosphotyrosine.
FT   MOD_RES     481    481       Phosphothreonine.
FT   MOD_RES     483    483       Phosphoserine.
FT   MOD_RES     486    486       Phosphoserine.
FT   MOD_RES     487    487       Phosphoserine.
FT   MOD_RES     489    489       Phosphoserine.
FT   VARIANT      96     96       S -> C (in dbSNP:rs2544773).
FT                                /FTId=VAR_042347.
FT   VARIANT     144    144       H -> R (in dbSNP:rs35165987).
FT                                /FTId=VAR_042348.
FT   VARIANT     144    144       H -> Y (in dbSNP:rs17849382).
FT                                /FTId=VAR_031597.
FT   VARIANT     155    155       R -> H (in dbSNP:rs34916955).
FT                                /FTId=VAR_042349.
FT   VARIANT     175    175       V -> I (in dbSNP:rs35713904).
FT                                /FTId=VAR_042350.
FT   VARIANT     216    216       I -> T (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042351.
FT   VARIANT     244    244       M -> V (in dbSNP:rs33996030).
FT                                /FTId=VAR_042352.
FT   VARIANT     349    349       G -> R (in dbSNP:rs160632).
FT                                /FTId=VAR_031598.
FT   VARIANT     397    397       N -> S (in dbSNP:rs12188395).
FT                                /FTId=VAR_031599.
FT   VARIANT     409    409       E -> D (in dbSNP:rs35829000).
FT                                /FTId=VAR_042353.
FT   VARIANT     507    507       R -> H (in dbSNP:rs34555783).
FT                                /FTId=VAR_042354.
SQ   SEQUENCE   552 AA;  63283 MW;  6EB260E72DDB78D7 CRC64;
     MGKVNVAKLR YMSRDDFRVL TAVEMGMKNH EIVPGSLIAS IASLKHGGCN KVLRELVKHK
     LIAWERTKTV QGYRLTNAGY DYLALKTLSS RQVVESVGNQ MGVGKESDIY IVANEEGQQF
     ALKLHRLGRT SFRNLKNKRD YHKHRHNVSW LYLSRLSAMK EFAYMKALYE RKFPVPKPID
     YNRHAVVMEL INGYPLCQIH HVEDPASVYD EAMELIVKLA NHGLIHGDFN EFNLILDESD
     HITMIDFPQM VSTSHPNAEW YFDRDVKCIK DFFMKRFSYE SELFPTFKDI RREDTLDVEV
     SASGYTKEMQ ADDELLHPLG PDDKNIETKE GSEFSFSDGE VAEKAEVYGS ENESERNCLE
     ESEGCYCRSS GDPEQIKEDS LSEESADARS FEMTEFNQAL EEIKGQVVEN NSVTEFSEEK
     NRTENYNRQD GQRVQGGVPA GSDEYEDECP HLIALSSLNR EFRPFRDEEN VGAMNQYRTR
     TLSITSSGSA VSCSTIPPEL VKQKVKRQLT KQQKSAVRRR LQKGEANIFT KQRRENMQNI
     KSSLEAASFW GE
//
